FDA Preemption Comment Could Sway California Against Prop 65 Warnings For Acetaminophen

 Food and drug attorneys suggest it is unlikely California will require Prop 65 warnings on OTC acetaminophen products after FDA tells the state that warnings would violate federal regulations. FDA also says sciences doesn't support a conclusion acetaminophen can cause cancer and that the warnings would confuse consumers.

Prop 65

More from Regulation

More from Policy & Regulation